Opioid Treatment Surge Act

United States116th CongressHR-3105House of Representatives
Updated: Jun 6, 2019

Summary

Opioid Treatment Surge Act This bill requires the Department of Health and Human Services to assess market-share-based fees, for the next 10 years, on drug manufacturers that have produced opioid drugs since 1999. Opioid drugs manufactured to treat opioid addiction, cancer patients, or hospice patients are, however, exempt from this assessment. All assessed fees must be used for the substance abuse prevention and treatment block grant program.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

S-1662: Opioid Treatment Surge Act

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  1. Introduced in House

  2. Referred to the House Committee on Energy and Commerce.

    House of Representatives

  3. Referred to the Subcommittee on Health.

    House of Representatives

All available records shown.